Vireo Growth Inc. (VREOF)

↓ Download CSV

CIK 0001771706 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated A1
  • Fiscal year ends Dec 31

In fiscal 2025, Vireo Growth Inc. reported revenue of $268.77M, up 170.4% from the prior year. The company ran a net loss, with a net margin of -25.3% and a gross margin of 47.3%. It held $817.15M in total assets against $509.73M in total liabilities.

Key ratios (FY2025)

47.3%
Gross margin
-0.4%
Operating margin
-25.3%
Net margin
-22.2%
Return on equity
+170.4%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019
Revenue$268.77M$99.38M$88.13M$74.63M$54.45M$49.21M
Cost of Revenue$39.42M$32.01M$31.11M
Gross Profit$127.10M$50.77M$44.10M$30.91M$19.80M$17.13M
Operating Income-$1.05M$13.56M$10.58M-$6.94M-$20.48M-$23.04M
Net Income-$68.11M-$28.01M-$25.55M-$42.46M-$33.69M-$22.94M
EPS (Diluted)$-0.09$-0.16$-0.19$-0.33$-0.27$-0.24
Total Assets$817.15M$278.86M$183.26M$159.16M$166.97M$102.63M
Total Liabilities$509.73M$223.30M$199.31M$155.72M$123.96M$40.28M
Shareholders' Equity$307.42M$55.56M-$16.04M$3.44M$43.01M$62.35M$48.69M
Operating Cash Flow$3.71M-$10.23M-$965.9K-$18.07M-$30.52M-$10.93M
Capital Expenditures$28.32M$11.69M$4.96M$5.56M$18.04M$8.45M
Shares Outstanding734.74M180.39M135.24M128.13M123.81M97.55M